Jonathan Yon
Stock Analyst at Credit Suisse
(2.06)
# 3,018
Out of 5,132 analysts
16
Total ratings
54.55%
Success rate
4.87%
Average return
Main Sectors:
Stocks Rated by Jonathan Yon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Outperform | $163 → $169 | $234.81 | -28.03% | 3 | Jul 27, 2023 | |
| PRVA Privia Health Group | Reiterates: Outperform | $41 | $22.39 | +83.12% | 2 | Jun 22, 2023 | |
| CYH Community Health Systems | Maintains: Neutral | $8.5 → $7.4 | $3.42 | +116.37% | 1 | May 3, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $31 → $32 | $8.08 | +296.28% | 1 | Feb 23, 2023 | |
| SLQT SelectQuote | Maintains: Neutral | $1 → $3 | $0.89 | +235.27% | 1 | Feb 22, 2023 | |
| MD Pediatrix Medical Group | Maintains: Outperform | $27 → $23 | $21.52 | +6.88% | 3 | Feb 22, 2023 | |
| HCA HCA Healthcare | Maintains: Outperform | $296 → $260 | $540.29 | -51.88% | 1 | Apr 25, 2022 | |
| CLOV Clover Health Investments | Downgrades: Underperform | $9 → $3.5 | $2.02 | +73.27% | 2 | Jan 7, 2022 | |
| CI The Cigna Group | Maintains: Outperform | $270 → $300 | $291.44 | +2.94% | 1 | Nov 8, 2021 | |
| CNC Centene | Maintains: Neutral | $74 → $70 | $40.58 | +72.50% | 1 | Sep 14, 2021 |
Universal Health Services
Jul 27, 2023
Maintains: Outperform
Price Target: $163 → $169
Current: $234.81
Upside: -28.03%
Privia Health Group
Jun 22, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.39
Upside: +83.12%
Community Health Systems
May 3, 2023
Maintains: Neutral
Price Target: $8.5 → $7.4
Current: $3.42
Upside: +116.37%
Cross Country Healthcare
Feb 23, 2023
Maintains: Neutral
Price Target: $31 → $32
Current: $8.08
Upside: +296.28%
SelectQuote
Feb 22, 2023
Maintains: Neutral
Price Target: $1 → $3
Current: $0.89
Upside: +235.27%
Pediatrix Medical Group
Feb 22, 2023
Maintains: Outperform
Price Target: $27 → $23
Current: $21.52
Upside: +6.88%
HCA Healthcare
Apr 25, 2022
Maintains: Outperform
Price Target: $296 → $260
Current: $540.29
Upside: -51.88%
Clover Health Investments
Jan 7, 2022
Downgrades: Underperform
Price Target: $9 → $3.5
Current: $2.02
Upside: +73.27%
The Cigna Group
Nov 8, 2021
Maintains: Outperform
Price Target: $270 → $300
Current: $291.44
Upside: +2.94%
Centene
Sep 14, 2021
Maintains: Neutral
Price Target: $74 → $70
Current: $40.58
Upside: +72.50%